Leading drugmaker Sun Pharma is doubling down on its specialty portfolio, launching new products and ramping up ...
52m
Jushi Holdings (JUSHF): Losses Narrowed 15% per Year, Strong Valuation Challenges Bearish Narratives
Jushi Holdings (JUSHF) remains unprofitable but has trimmed its losses by an average of 15% per year over the past five years, with revenue projected to grow 8.1% per year. This is slower than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback